Genetic Influences in Common Respiratory Disorders

Critical Care Nursing Clinics of North America

Volumn 20, Issue 2, 2008, Pages 171-189

  Workman, M Linda ^a   Winkelman, Chris ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; BIOLOGICAL MODEL; BREATHING DISORDER; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; ENVIRONMENTAL DISEASE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; HUMAN; INNATE IMMUNITY; INTENSIVE CARE; LUNG TUBERCULOSIS; LUNG TUMOR; NORTH AMERICA; REVIEW; SMOKING;

ADULT; CAUSALITY; CHILD; CRITICAL CARE; CYSTIC FIBROSIS; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL ILLNESS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; IMMUNITY, NATURAL; LUNG NEOPLASMS; MODELS, BIOLOGICAL; NORTH AMERICA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION DISORDERS; RESPIRATORY DISTRESS SYNDROME, ADULT; SMOKING; TUBERCULOSIS, PULMONARY; VARIATION (GENETICS);

EID: 42049094244     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2008.01.009     Document Type: Review

References (60)

1. Workman M.L. The cellular basis of bacterial infection. Crit Care Nurs Clin North Am 15 1 (2003) 1-11
2. Nussbaum R., McInnes R., and Willard H. Thompson & Thompson: genetics in medicine. 7th edition (2007), W.B. Saunders, Philadelphia
3. Pier G.B., Grout M., Zaidi T., et al. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393 (1998) 79-82
4. Quinton P.M. Physiological basis of cystic fibrosis: a historical perspective. Physiol Rev 79 Suppl (1999) S3-S22
5. Andersen D.H. Cystic fibrosis of the pancreas and its relation to celiac disease. Am J Dis Child 56 (1938) 344-399
6. Andersen D.H., and Hodges R. Celiac syndrome. V. Genetics of cystic fibrosis of the pancreas with a consideration of the etiology. Am J Dis Child 72 (1946) 62-80
7. di Sant'agnese P.A., Darling R.C., Perera G.A., et al. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas. Pediatrics 12 (1953) 549-563
8. Thomaidis T.S., and Arey J.B. The intestinal lesions in cystic fibrosis of the pancreas. J Pediatr 63 (1963) 444-453
9. Holsclaw D.S., Perelmutter A.D., Jockin H., et al. Genital abnormalities in males with cystic fibrosis: an emerging problem. J Urol 106 (1971) 568-574
10. Tsui L.-C., Buchwald M., Barker D., et al. Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science 230 (1985) 1054-1057
11. Kerem B., Rommens J.M., Buchanan J.A., et al. Identification of the cystic fibrosis gene: genetic analysis. Science 245 (1989) 1073-1080
12. Reddy M.M., and Quinton P.M. Control of dynamic CFTR selectivity by glutamate and ATP in epithelial cells. Nature 423 (2003) 756-760
13. Kulczycki L., Kostuch M., and Bellanti J. A clinical perspective of cystic fibrosis and new genetic findings: relationship of CFTR mutations to genotype-phenotype manifestations. Am J Med Genet 116 (2003) 262-267
14. Kerem E., Corey M., Kerem B., et al. The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (delta-F508). N Engl J Med 323 (1990) 1517-1522
15. Grossman S., and Grossman L.C. Pathophysiology of cystic fibrosis: implications for critical care nurses. Crit Care Nurse 25 4 (2005) 46-51
16. Gardner J. What you need to know about cystic fibrosis. Nursing 37 7 (2007) 52-55
17. Kumar V., Abbas A., and Fausto N. Robbins and Cotran pathologic basis of disease. 7th edition (2005), W.B. Saunders, Philadelphia
18. Chappell S., Daly L., Morgan K., et al. Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. Hum Mutat 27 (2006) 103-109
19. Coakley R., Taggart C., O'Neill S., et al. alpha(sub1)-antitrypsin deficiency: biological answers to clinical questions. Am J Med Sci 321 1 (2001) 33-41
20. Kueppers F., Briscoe W.A., and Bearn A.G. Hereditary deficiency of serum alpha-1-antitrypsin. Science 146 (1964) 1678-1679
21. Laurell C.B., and Eriksson S. The serum of alpha-1-antitrypsin in families with hypo-alpha-1-antitrypsinemia. Clin Chim Acta 11 (1965) 395-398
22. Tarkoff M.P., Kueppers F., and Miller W.F. Pulmonary emphysema and alpha-1-antitrypsin deficiency. Am J Med 45 (1968) 220-228
23. Guenter C.A., Welch M.H., and Hammarsten J.F. Alpha-1-antitrypsin deficiency and pulmonary emphysema. Annu Rev Med 22 (1971) 283-292
24. Crystal R.G. Alpha-1-antitrypsin deficiency, emphysema, and liver disease: genetic basis and strategies for therapy. J Clin Invest 85 (1990) 1343-1352
25. Darlington G.J., Astrin K.H., Muirhead S.P., et al. Assignment of human alpha-1-antitrypsin to chromosome 14 by somatic cell hybrid analysis. Proc Natl Acad Sci U S A 79 (1982) 870-873
26. Cox D.W., Billingsley G.D., Mansfield T., et al. DNA restriction-site polymorphisms associated with the alpha-1-antitrypsin gene. Am J Hum Genet 41 (1987) 891-906
27. Curiel D.T., Vogelmeier C., Hubbard R.C., et al. Molecular basis of alpha-1-antitrypsin deficiency and emphysema associated with the alpha-1-antitrypsin M(Mineral Springs) allele. Mol Cell Biol 10 (1990) 47-56
28. DeCroo S., Kamboh M.I., and Ferrell R.E. Population genetics of alpha-1-antitrypsin polymorphism in US whites, US blacks and African blacks. Hum Hered 41 (1991) 215-221
29. Blanco I., Bustillo E.F., and Rodriguez M.C. Distribution of alpha-1-antitrypsin PI S and PI Z frequencies in countries outside Europe: a meta-analysis. Clin Genet 60 (2001) 431-441
30. de Serres F.J., Blanco I., and Fernandez-Bustillo E. Genetic epidemiology of alpha-1-antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America. Clin Genet 64 (2003) 382-397
31. Faber J.P., Poller W., Weidinger S., et al. Identification and DNA sequence analysis of 15 new alpha-1-antitrypsin variants, including two Pi* Q alleles and one deficient Pi* M allele. Am J Hum Genet 55 (1994) 1113-1121
32. Stoller J.K. Clinical features and natural history of severe alpha(sub1)-antitrypsin deficiency. Chest 111 6 (1997) 123s-128s
33. Harrison H.H., Miller K.L., and Whitington P.F. Improved detection, via ISO-DALT two-dimensional electrophoresis, of 'low Z expressor' individuals with alpha-1-antitrypsin MZ phenotype. Clin Chem 36 (1990) 1850-1851
34. Seri M., Magi B., Cellesi C., et al. Molecular characterization of the P and I variants of alpha-1-antitrypsin. Int J Clin Lab Res 22 (1992) 119-121
35. Klaassen C.H., deMetz M., van Aarssen Y., et al. Alpha(1)-antitrypsin deficiency as a result of compound heterozygosity for the Z and M(Heerlen) alleles. Clin Chem 47 5 (2001) 978-979
36. Dahl M., Tybjaerg-Hansen A., Lange P., et al. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha-1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 136 (2002) 270-279
37. American Cancer Society. Cancer facts and figures 2007. Report No. 01-300M-No. 5008.07. Atlanta: American Cancer Society; 2007.
38. Warburton D., and Oliver R. Coordination of genetic, epigenetic, and environmental factors in lung development, injury, and repair. Chest 111 6 (1997) 119S-122S
39. Spitz M.R., Wei Q., Li G., et al. Genetic susceptibility to tobacco carcinogenesis. Cancer Invest 17 8 (1999) 645-659
40. Laforest L., Wikman H., Benhamou S., et al. CYP2D6 gene polymorphism in Caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships. Eur J Cancer 36 14 (2000) 1825-1832
41. Kiyohara C., Otsu A., Shirakawa T., et al. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 37 (2002) 241-256
42. Wu X., Zhao H., Suk R., et al. Genetic susceptibility to tobacco-related cancer. Oncogene 23 38 (2004) 6500-6523
43. Haiman C.A., Stram D.O., Wilkens L.R., et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med 354 (2006) 333-342
44. Tang D.L., Rundle A., Warburton D., et al. Association between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis 19 11 (1998) 1949-1953
45. Wu A.H., Fontham E.T., and Reynolds P. Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 143 (1996) 535-542
46. Hwang S.J., Cheng L.S., Lozano G., et al. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum Genet 113 3 (2003) 238-243
47. Zhang X., Mioa X., Guo Y., et al. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Hum Mutat 27 1 (2006) 110-117
48. Pao W., Miller V., Zakowski M., et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A 101 (2004) 13306-13311
49. Bauer T.T., Ewig S., Rodloff A.C., et al. Acute respiratory distress syndrome and pneumonia: A comprehensive review of clinical data. Clin Infect Dis 43 6 (2006) 748-756
50. Winkelman C. Inflammation and genomics in the critical care unit. Crit Care Nurs Clin North Am 20 2 (2008) 213-221
51. Jiang D., Liang J., Fan J., et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11 (2005) 1173-1179
52. Farjanel J., Hartmann D.J., Guidet B., et al. Four markers of collagen metabolism as possible indicators of disease in the adult respiratory distress syndrome. Am Rev Respir Dis 147 5 (1993) 1091-1099
53. Strauss E.J., and Falkow S. Microbial pathogenesis: genomics and beyond. Science 276 5313 (1997) 707-713
54. World Health Organization: Global tuberculosis control. WHO Report 2005 (2000), World Health Organization
55. Khor C.C., Chapman S.J., Vannberg F.O., et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 39 (2007) 523-528
56. Hsu L.C., Park J.M., Zhong K., et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428 (2004) 341-345
57. Pieters J. Entry and survival of pathogenic mycobacteria in macrophages. Microbes Infect 3 3 (2001) 249-255
58. Greenwood C.M., Fujiwara T.M., Boothroyd L.J., et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 67 2 (2000) 405-416
59. Malik S., Abel L., Tooker H., et al. Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease. Proc Natl Acad Sci U S A 102 34 (2005) 12183-12188
60. Abel L., and Casanova J. Genetic predisposition to clinical tuberculosis: bridging the gap between simple and complex inheritance. Am J Hum Genet 67 (2000) 274-277